Please complete the CAPTCHA to continue
@abbott.com
✓
5 phones found area 847 and 224
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Hubbard, Ph.D. is listed as Operator in Residence | Chief Scientific Officer | Drug Developer | Medicinal Chemist at Stealth Mode Biotech, based in San Diego, California, United States. AeroLeads shows a work email signal at abbott.com, phone signal with area code 847, 224, and a matched LinkedIn profile for Robert Hubbard, Ph.D..
Robert Hubbard, Ph.D. previously worked as Chief Scientific Officer (Interim) at Stealth Mode Biotech and Head of Medicinal Chemistry at Violet Therapeutics. Robert Hubbard, Ph.D. holds Chemistry from Stanford University.
This section adds company-level context without repeating Robert Hubbard, Ph.D.'s masked contact details.
AeroLeads found 2 current-domain work email signals for Robert Hubbard, Ph.D.. Compare company email patterns before reaching out.
At the forefront of oncology innovation, my role as Chief Scientific Officer at Stealth Mode Biotech involves steering a groundbreaking platform approach in drug discovery, encompassing chemistry, pharmacology, and DMPK. Our mission is to transform oncology treatment, and my leadership in fundraising is pivotal in scaling this ambitious platform.My tenure as Head of Medicinal Chemistry at Violet Therapeutics showcases my mastery in executing medicinal chemistry on neurodegeneration targets and managing CROs. The experience has honed my competencies in research project management and biochemistry, with a focus on kinase modulation, advancing the field and contributing to the development of transformative therapeutic solutions.
Listed skills include Organic Chemistry, Chemistry, Medicinal Chemistry, Drug Discovery, and 43 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Sevenoaks, Gb
Developing strategy for a novel platform approach for oncologyManaging all aspects of drug discovery - chemistry, pharmacology and DMPKParticipating in fundraising to support platform expansion
Cambridge, Ma, Us
Execution of medicinal chemistry on a novel target for neurodegenerationDiligence novel targets from the RABID-seqManaging external CROs across medicinal chemistry and ADME/DMPK
Cambridge, Ma, Us
Operator in Residence for Amplify, which is a pre-commercial translation program at MGB Innovation. Identification of technologies (diagnostics, therapeutics, devices) with high commercial potential within the MGB system. Interaction with KOLs and VCs both internal and external to MGBSeed-level company creation
Communicate objectives and timing of research deliverables to Board and FoundersMeet with VCs to discuss the science of our novel approach to protein degradationResponsible for cross-discipline CRO management
San Diego, Ca, Us
Project Team Leader focused on harnessing targeted protein degradation towards novel biological target classes.Optimized covalent ligand hits to potent targeted protein degraders.Managed a team of both internal and external chemists. Performed in silico assessment of physical properties of complex synthetic targets
San Diego, California, Us
• Expand client base and define new opportunities for Crown Bioscience along the West Coast, focusing in Southern California• Present Crown Bioscience’s vast capabilities (in vitro/ in vivo) in the Oncology and Immuno-Oncology space
Summit, New Jersey, Us
• Orchestrated delivery of a “First-In-Class” kinase inhibitor from the initial synthesis to candidate nomination. Unified project team to streamline timeline requiring key assays be performed in parallel to accommodate aggressive timelines.• Parlayed chemical matter from a novel cell-based screen through H2L, LI, LO • Communicated the team goals and project team progress to senior management on a quarterly basis. • Worked with various disciplines (in vitro/ in vivo pharmacology, DMPK, toxicology, biochemistry) to address critical project issues. • Managed collaborations between Celgene and various external Contract Research Organizations (US, China, Europe), teams ranging from 2-10 FTE.• Capitalized on recent interest on immune checkpoint biologics by advocating exploring small-molecule therapeutics for Immuno-oncology. Collaborated with scientists across three sites to craft a cohesive small-molecule effort. • Provided guidance to both internal and external chemists on a project that advanced from H2L to candidate nomination, teams sizes ranged from 6-14 FTEs.• Leveraged external resources to synthesize novel toxin constructs for antibody drug conjugates, providing substantial increase in drug to antibody loading.• Established/ facilitated research collaborations with cutting-edge CROs. Drafted research plans; worked with the Legal and Contracts groups to craft Confidentiality & Master Service agreements. Managed budgets
Abbott Park, Illinois, Us
• Analyzed patent literature to define optimal conjugation procedures and payloads for internal antibody drug conjugate testing. • Augmented Abbott’s computational team and performed in silico docking and scoring simulations to find novel chemical matter for Epigenetic targets. Cheminformatic tools used: Maestro, Pipeline Pilot, Seurat, Spotfire.
Abbott Park, Illinois, Us
• Recruited/managed Biochemist, Medicinal Chemist, Pharmaceutical Development Scientist and Nucleic Acid Chemist to generate novel platform for in vivo delivery of siRNA. • Directed the synthesis of innovative lipids for formulation into siRNA-based nanoparticles.• Successfully synthesized the complex natural product, Pladienolide, an instrumental material for validating a novel oncology target. • Launched a Fragment-Based Drug Design effort utilizing a Nuclear Magnetic Resonance screen. Elaboration of resulting identified matter led to nomination of a Preclinical Candidate.
Abbott Park, Illinois, Us
• Proposed literature inspired kinase program. Examined screening hits from a previous HTS screen and determined a different construct of the protein was needed. • Developed chemical matter from the subsequent screen using SBDD. Prepared mg to kg quantities of intermediates and/ or final compounds for the project team.• Initiated a cell-based screen to identify novel Oncology targets. Triaged hits from High-Throughput Screening (HTS) campaign to identify tractable chemical matter.
Brentford, Middlesex, Gb
• Optimized a series of kinase inhibitors for an oncology indication. • Structure Activity Relationship (SAR) evaluation of the scaffold revealed a novel mechanism of irreversibility inhibiting the target kinase. • Generated a class of potent, stable and selective irreversible inhibitors of the ErbB-family of receptor tyrosine kinases.
Stanford, Ca, Us
Completed the total synthesis of (-)-Laulimalide and developed two novel Rh-catalyzed reactions.
Quick answers generated from the profile data available on this page.
Robert Hubbard, Ph.D. works for Stealth Mode Biotech.
Robert Hubbard, Ph.D. is listed as Operator in Residence | Chief Scientific Officer | Drug Developer | Medicinal Chemist at Stealth Mode Biotech.
AeroLeads has found 2 work email signals at @abbott.com for Robert Hubbard, Ph.D. at Stealth Mode Biotech.
AeroLeads has found 5 phone signal(s) with area code 847, 224 for Robert Hubbard, Ph.D. at Stealth Mode Biotech.
Robert Hubbard, Ph.D. is based in San Diego, California, United States while working with Stealth Mode Biotech.
Robert Hubbard, Ph.D. has worked for Stealth Mode Biotech, Violet Therapeutics, Mass General Brigham Innovation, Coho Therapeutics, and Vividion Therapeutics.
You can use AeroLeads to view verified contact signals for Robert Hubbard, Ph.D. at Stealth Mode Biotech, including work email, phone, and LinkedIn data when available.
Robert Hubbard, Ph.D. holds Chemistry from Stanford University.
Robert Hubbard, Ph.D. is listed with skills including Organic Chemistry, Chemistry, Medicinal Chemistry, Drug Discovery, Pharmaceutical Industry, Lc Ms, Lead Change, and Drug Design.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts